US/UK/Canada

Share

Quotes

With more than 300,000 deaths over the last eight years, substance abuse has been killing more people than any war.
Dr. Sanjay Gupta, President American Pain Association
Education and compassion are essential to achieving global acceptance of and access to cannabis.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"...may we reflect on how far we have come and continue to work toward the common goal of global cannabis access"
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"The goal of these new advances in cannabis-based medicine – and the reintroduction of cannabis in healthcare – is to leave an indelible mark on the healthcare industry."
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
It is clear that cannabis has reached the tipping point in the minds of the U.S. population.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
“It is clear that cannabis has reached the tipping point in the minds of the U.S. population.”
Dr. Stuart Titus, CEO - Medical Marijuana, Inc.
Pick a time period -
Tags ( Active)

Medical Marijuana, Inc. Subsidiary HempMeds ® Announces Formation of Business Operations in Chile, Begins Importation Into Argentina

Company Continues International Expansion Initiatives with Company Formation in Chile and Begins Importing Real Scientific Hemp Oil™ to Argentinian MarketMedical Marijuana, Inc.  (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary company HempMeds®  has formed a new business in Chile. Additionally, as part of the company’s Latin American market expansion initiative, the company has begun importing their flagship product Real Scientific Hemp Oil™ (RSHO™) (

NEWSWEEK COVER STORY DOCUMENTS MEDICAL MARIJUANA, INC.’S FIRST-EVER FEDERALLY APPROVED CBD PRODUCT IN MEXICO RSHO-X™

HempMeds® Mexico  Continues Education, Expansion, Advancements in Mexico as Demand Increases for its RSHO-X™ Across CountryMedical Marijuana, Inc.  (OTC PINK: MJNA) announced today that Newsweek featured its subsidiary HempMeds® Mexico ‘s non-psychoactive, THC-free hemp-based cannabidiol (CBD) product Real Scientific Hemp Oil-X™  (RSHO-X™), the first-ever

FORBES ARTICLE FEATURES MEDICAL MARIJUANA, INC.’S PIONEERING ROLE IN LATIN AMERICA’S BURGEONING CANNABIS MARKET

Medical Marijuana, Inc.  (OTC: MJNA) announced today that it was the focus of a Mexico Forbes article that discusses the company’s pioneering role in expanding access to medical cannabinoid products to people across Latin America, including bringing the first legal cannabis products to Mexico, Brazil and Paraguay. The Sept. 19 Mexico Forbes article titled, “Cotiza en los mercados y quiere vender medicina de marihuana en México ,” describes how

MEDICAL MARIJUANA, INC. CEO INTERVIEWED FOR UPTICK NEWSWIRE; DISCUSSES LATIN MARKET EXPANSION, PORTFOLIO COMPANIES KANNAWAY AND AXIM BIOTECH

Medical Marijuana, Inc.  (OTC: MJNA) announced today that the Company’s Chief Executive Officer Dr. Stuart Titus was interviewed by the Uptick Network’s Stock Day Radio Show  about expanding access to cannabidiol (CBD)-based products to people across Latin America, recent developments for its pharmaceutical and biotechnology investment portfolio companies, and investing in the booming cannabis industry. “Our mission is to change the way the world thinks about

MONEY SHOW ARTICLE FEATURES MEDICAL MARIJUANA, INC.’S LEADING ROLE IN THE WORLD’S FASTEST-GROWING GLOBAL INDUSTRY: CANNABIS

First-Ever Publicly Traded Cannabis Company in U.S. to Sponsor Money Show’s Cannabis Investing Symposium in San Francisco; CEO to Discuss Global Trends and Investment OpportunitiesMedical Marijuana, Inc.  (OTC: MJNA) announced today that the Company was featured in a Money Show article  about its leading role in the world’s fastest growing industry: cannabis. The Company also announced that it is sponsoring The San Francisco Money Show’s Cannabis Investing Symposium 

There are no items matching the current filter
There are no more items matching the current filter
Back to top